Seventeen-year experience with 1,083 heart transplants at a single institution

Annals of Thoracic Surgery

Volumn 74, Issue 5, 2002, Pages 1558-1567

  Marelli, Daniel ^a,b   Laks, Hillel ^a   Kobashigawa, Jon A ^a   Bresson, Jessica ^a   Ardehali, Abbas ^a   Esmailian, Fardad ^a   Plunkett, Mark D ^a   Kubak, Bernard ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CONGENITAL HEART DISEASE; CORONARY ARTERY DISEASE; GRAFT REJECTION; HEART FAILURE; HEART TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION CONTROL; ISCHEMIC HEART DISEASE; PRIORITY JOURNAL; SURVIVAL;

ADOLESCENT; ADULT; AGE FACTORS; AGED; CAUSE OF DEATH; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; HEART FAILURE, CONGESTIVE; HEART TRANSPLANTATION; HUMANS; INFANT; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; TISSUE DONORS;

EID: 0036840594     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(02)03933-4     Document Type: Article

References (12)

1. www.unos.org.
2. Franco-Cereceda A, McCarthy PM, Blackstone EH, et al. Partial left ventriculectomy for dilated cardiomyopathy: is this an alternative to transplantation? J Thorac Cardiovasc Surg 2001;121:879-93.
3. Rajnoch C, Chachques JC, Berrebi A, et al. Cellular therapy reverses myocardial dysfunction. J Thorac Cardiovasc Surg 2001;121:871-8.
4. Fonarow G, Feliciano Z, Boyle N, et al. Improved survival in patients with nonischemic advanced heart failure, and syncope treated with an implantable cardioverter-defibrillator. Am J Cardiol 2000;85:981-5.
5. Renlund DG, Taylor DO, Kfoury AG, Shaddy RS. New UNOS rules. Historical background and implications for transplantation management. J Heart Lung Transplant 1999; 18:1065-70.
6. Kobashigawa JA, Katznelson S, Laks H, et al. Effect of pravastatin on outcomes after cardiac transplantation. N Engl J Med 1995;333:621-7.
7. Laks H, Marelli D, Fazio D, Kobashigawa J. Expanding the heart donor base. Curr Opin Organ Transplant 2000;5:134-8.
8. Laks H, Marelli D. The Alternate Recipient List for Heart Transplantation: A Model for Expansion of the Donor Pool. Advances in Cardiac Surgery 1999;11:233-44.
9. Mudge GH, Goldstein S, Addonizio LJ, et al. Bethesda Conference on Transplantation Task Force. Recipient guidelines/prioritization. J Am Coll Cardiol 1993;22:21-31.
10. Ardehali A, Hughes K, Sadeghi A, et al. Inhaled nitric oxide for pulmonary hypertension after heart transplantation. Transplantation 2001;72:638-41.
11. Kobashigawa JA, Miller I, Renlund D, et al. A randomized active-controlled trial of mycophenolate mofetil in heart transplant recipients. Mycophenolate Mofetil Investigators. Transplantation 1998;66:507-15.
12. Young JB, Naftel DC, Bourge RC, et al. Matching the heart donor and heart transplant recipient: Clues for successful expansion of the donor pool: A multivariate, multi-institutional report. J Heart Lung Transplant 1994;13:353-65.